Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™) - Distler, O; Brown, K K; Distler, J HW (Clin Exp Rheumatol, 2017)
et al.